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Background
The use of human embryonic kidney cells (HEK293) for
recombinant protein or virus production has gained
relevance along the last years. They are specially recom-
mended for transient gene expression and adenovirus or
adeno-associated virus generation [1,2]. To achieve high
volumetric productivities towards bioprocess optimiza-
tion, the concentration of biocatalizer (i.e. animal cells)
must be enhanced. The limits for cell growth are mainly
related to the accumulation of metabolic by-products, or
the depletion of nutrients [3]; therefore, cell cultures
strategies must be developed. In this work, we have
explored Punctual Feeding and Media Replacement cell
culture strategies to over perform the limit on Xvmax
encountered on batch culture mode. Finally, we scaled
up cell culture in order to control other parameters (i.e.
pO2) that could be limiting cell growth.
Materials and methods
The cell line used in this study was HEK293SF-3F6
(kindly provided by Dr. A.Kamen, NRC-BRI). The basal
medium for all cell cultures was SFMTransFx-293
(Hyclone, Thermo Scientific) supplemented with 5%
(v/v) of FBS and 4 mM GlutaMAX (Gibco, Invitrogen).
For Punctual Feeding and FedBatch Fementation Cell
Boost 5 (Hyclone, Thermo Scientific) was used. Batch,
media replacement and punctual feeding experiments
were performed in 125-ml plastic shake flasks (Corning
Inc.) shaken at 110 rpm in an orbital shaker at 37°C,
95% humidity, 5% CO2 incubator. FedBatch Fermenta-
tion was carried out in Bioreactor Braun-MCD (2 L)
with mechanical agitation at 80 rpm, pH set point 7.1
and pO2 set point 50%. Viable cell density and viability
were determined by trypan blue exclusion method and
manual counting using a haemocytometer. Glucose and
lactate were analysed in an automatic analyser, YSI (Yel-
low Springs Instrument, 2700 Select).
Results
Characterization of HEK293 cell culture in batch opera-
tion was initially performed. It was encountered that cell
growth was extended for 168 h reaching approximately
7·106 cell/mL of cell density (Figure 1.1). Nevertheless,
maximal cell growth rate (μmax) was only maintained for
96 h. As glucose and lactate were not at limiting concen-
trations [4], nutrient limitation different from glucose
arose as the first hypothesis for this decrease on cell
growth rate. Therefore, punctual additions of nutritional
supplement for HEK293 were carried out. Xvmax was sig-
nificantly increased in comparison to basal media, reach-
ing cell densities as high as 17·106 cell/mL (Figure 1.2).
Nevertheless, we could not overcome this limit on Xvmax
regardless the number of punctual feedings performed.
Moreover, nutrient addition did not elongate μmax period
(tμ). These results suggested that by-product accumula-
tion different from lactate could be limiting cell growth.
In order to validate the hypothesis, complete media
replacement (up to three replacements) was studied
(Figure 1.3). Although this strategy enabled to extend tμ
up to 168 h of cell culture, the maximal cell density
reached was similar to nutrient addition strategy (1MR:
12·106 cell/mL; 2MR: 16·106 cell/mL; 3MR: 18·106 cell/
mL). This limit on Xvmax encountered on shake flask
might be related to a limitation on pO2. Thus, the cell
culture system was changed towards a bioreactor with
controlled pO2 (maintained between 20-60% of air
saturation). In addition, a continuous feeding using a
pre-fixed profile addition was implemented. As it can be
noticed in Figure 1.4, FedBatch operation in bioreactor
enabled to beat the limit encountered in shake flask sys-
tem, reaching cell densities of 27·106 cell/mL.
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Conclusions
Punctual feeding and media replacement overcame the
limit of 7·106 cell/mL encountered in batch mode opera-
tion indicating that nutrient depletion was one of the
causes of that limit. Nevertheless, the elongation of tμ
found out performing MR suggests that the accumula-
tion of by-products might not be ruled out.
The new limit on Xvmax (≈17-18·10
6 cell/mL)
encountered regardless the cell culture strategy, was
outperformed by transferring O2 more efficiently in
bioreactor system, reaching cell densities as high as
Xvmax = 27·10
6 cell/mL. The monitoring and control of
cell culture parameters (i.e. pO2, pH) will enable to
develop more accurate feeding strategies in order to
achieve higher cell densities than those presented here
(on going work).
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Figure 1 Comparison of HEK293 cell growth, viability, glucose and lactate profiles in different cell culture strategies.
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